These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding. Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146 [TBL] [Abstract][Full Text] [Related]
3. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database. Castillon G; Salvo F; Moride Y Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758 [TBL] [Abstract][Full Text] [Related]
5. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Reumerman M; Tichelaar J; Piersma B; Richir MC; van Agtmael MA Eur J Clin Pharmacol; 2018 Oct; 74(10):1235-1248. PubMed ID: 29926135 [TBL] [Abstract][Full Text] [Related]
6. Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi. Jusot V; Chimimba F; Dzabala N; Menang O; Cole J; Gardiner G; Ofori-Anyinam O; Oladehin O; Sambakunsi C; Kawaye M; Stegmann JU; Guerra Mendoza Y Drug Saf; 2020 Jun; 43(6):583-593. PubMed ID: 32239447 [TBL] [Abstract][Full Text] [Related]
7. The value of patient reporting to the pharmacovigilance system: a systematic review. Inácio P; Cavaco A; Airaksinen M Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545 [TBL] [Abstract][Full Text] [Related]
8. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Tandon VR; Mahajan V; Khajuria V; Gillani Z Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314 [TBL] [Abstract][Full Text] [Related]
9. Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK. Thompson A; Randall C; Howard J; Barker C; Bowden D; Mooney P; Munyika A; Smith S; Pirmohamed M J Clin Pharm Ther; 2019 Feb; 44(1):78-83. PubMed ID: 30206951 [TBL] [Abstract][Full Text] [Related]
10. Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years. Andreaggi CA; Novak EA; Mirabile ME; Sampathkumar S; Gray MP; He M; Kane-Gill SL Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1627-1635. PubMed ID: 32851782 [TBL] [Abstract][Full Text] [Related]
11. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia. Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354 [TBL] [Abstract][Full Text] [Related]
12. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese. Inácio P; Airaksinen M; Cavaco A Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069 [TBL] [Abstract][Full Text] [Related]
13. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions. Mulchandani R; Kakkar AK Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985 [TBL] [Abstract][Full Text] [Related]
14. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533 [TBL] [Abstract][Full Text] [Related]
15. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China. Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811 [TBL] [Abstract][Full Text] [Related]
16. Adverse drug reaction reporting in the Czech Republic 2005-2009. Kopečná E; Deščíková V; Vlček J; Mladá J Int J Clin Pharm; 2011 Aug; 33(4):683-9. PubMed ID: 21678040 [TBL] [Abstract][Full Text] [Related]
17. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Pal SN; Duncombe C; Falzon D; Olsson S Drug Saf; 2013 Feb; 36(2):75-81. PubMed ID: 23329541 [TBL] [Abstract][Full Text] [Related]
18. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study. Schutte T; van Eekeren R; Richir M; van Staveren J; van Puijenbroek E; Tichelaar J; van Agtmael M Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):17-26. PubMed ID: 29063137 [TBL] [Abstract][Full Text] [Related]
19. Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting. Aung AK; Tang MJ; Adler NR; de Menezes SL; Goh MSY; Tee HW; Trubiano JA; Puy R; Zubrinich CM; Graudins LV J Clin Pharmacol; 2018 Oct; 58(10):1332-1339. PubMed ID: 29733431 [TBL] [Abstract][Full Text] [Related]
20. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda. Katusiime B; Semakula D; Lubinga SJ Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]